SAN DIEGO, March 3, 2022 — Artiva Biotherapeutics, Inc., an oncology company with a mission to deliver highly effective, off-the-shelf, allogeneic natural killer (NK) cell-based therapies that are safe and accessible to cancer patients, today announced the appointment of Laura Bessen, M.D., as an independent member of the Company’s board of directors. Dr. Bessen brings…
